Back to results
UnknownPhase 2

Psilocybin Versus Ketamine in Treatment-Resistant Depression

NCT05383313

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Institute of Mental Health

Klecany, Czechia

Contact

Vivian Winkler, MD

+420773137373vivian.winkler@nudz.cz
View on ClinicalTrials.gov
Psilocybin Versus Ketamine in Treatment-Resistant Depression — TrialFind